Aspire Biopharma Holdings, Inc. (ASBP)
0.0959
-0.01
(-8.23%)
USD |
NASDAQ |
Dec 12, 16:00
0.117
+0.02
(+22.00%)
After-Hours: 20:00
Aspire Biopharma Holdings Shareholders Equity (Quarterly): -11.47M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Salarius Pharmaceuticals, Inc. | 4.248M |
| Taysha Gene Therapies, Inc. | 218.99M |
| Olema Pharmaceuticals, Inc. | 307.49M |
| Invivyd, Inc. | 93.07M |
| MSP Recovery, Inc. | -563.84M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.403M |
| Total Liabilities (Quarterly) | 13.87M |
| Debt to Equity Ratio | -0.7521 |
| Current Ratio | 0.1734 |
| Net Debt Paydown Yield | -6.41% |